🇺🇸 FDA
Pipeline program

Berberine plus lifestyle intervention

2021-CXGC04-2

Approved small_molecule completed

Quick answer

Berberine plus lifestyle intervention for Obesity is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Obesity
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials